Kelley Drye & Warren LLP

Michael Adelstein, chair of the Securities and Capital Markets group at Kelley Drye & Warren LLP, advises on a range of corporate and M&A matters. He is an experienced legal advisors in the field of complex capital markets transactions and strategic investments. Key recent work includes representing IMAC Holdings, Inc. in its restructuring and acquisition of Theralink Technologies, Inc., along with subsequent convertible preferred stock and warrant offerings to institutional investors.